BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Amanta Healthcare Ltd. Share Price

NSE
BSE

NSE : AMANTA

BSE : 544502

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹196.76

High

₹205.57

Price Summary

Previous Close ₹205.17
Day's Range ₹196.76 - ₹205.57
Open ₹198.70
52 Week Range ₹92.00 - ₹195.83
Volume 2,61,042
Market Cap ₹0.00
Previous Close ₹205.10
Day's Range ₹197.35 - ₹205.10
Open ₹200.00
52 Week Range ₹93.10 - ₹195.35
Volume 12,070
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 535.58
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 51.69
TTM EPS (₹) 3.78
P/E Ratio 0.00
Book Value(₹) 3.39
PAT Margin (%) 3.82
Face Value (₹) 10.00
ROCE(%) 15.16
Trade Value ( ₹ in Lacs) 24.76
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 51.69
TTM EPS (₹) 3.78
P/E Ratio 0.00
Book Value(₹) 3.39
PAT Margin (%) 3.82
Face Value (₹) 10.00
ROCE(%) 15.16

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 653.07 2747.08
Expenses N/A N/A
PBT 49.26 147.06
Operating profit 0.0 0.0
Net profit 35.07 105.01

Shareholding Pattern

Promoters (% Holding)

63.80%

Mutual funds (% Holding)

5.33%

Non-Institution (% Holding)

22.85%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.43%

About Amanta Healthcare Ltd.

Founded 1994
Managing Director Bhavesh Patel
NSE Symbol AMANTA

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,56,089.58 1,909.90 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 2,26,975.64 8,500.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,85,638.53 4,860.85 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,24,503.13 8,700.00 6,696.50 - 6,696.50
Cipla Ltd. 1,15,216.02 1,435.00 1,165.70 - 1,165.70
Lenskart Solutions Ltd. 1,15,063.80 654.70 0.00 - 0.00
Zydus Lifesciences Ltd. 1,11,720.43 1,101.00 835.50 - 835.50
Lupin Ltd. 1,00,271.61 2,190.00 1,875.00 - 1,875.00
Dr. Reddy's Laboratories Ltd. 98,074.41 1,194.50 1,101.00 - 1,101.00
Laurus Labs Ltd. 98,047.76 1,796.25 823.10 - 823.10
no-content No Records Found

Latest News

Aug
24
2026
EQUITY Posted on Aug 24th 2026

Amanta Healthcare informs about annual report

Amanta Healthcare has informed that the 31st Annual General Meeting of the Company will be held on Wednesday, September 16, 2026, through Video Conferencing (VC) / Other Audio - Visual Means (OAVM), at 12:00 PM to transact the businesses as set out in the Notice, pursuant to the relevant circulars issued in this regard by the Ministry of Corporate Affairs and under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). Pursuant to Regulations 30 and 34 of the Listing Regulations, it has enclosed Annual Report for the Financial Year 2025-26 and the Notice convening 31st AGM of the Company. The aforesaid documents are available on the website of the Company at www.amanta.co.in and are being dispatched electronically to shareholders whose email addresses are registered with the Company and Depositories. Further, pursuant to Regulation 36(1)(b), the Company has initiated sending physical letters providing the weblink to access the Annual Report to the shareholders whose e-mail ids are not registered with the Company/Depositories/RTA.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
3
2026
EQUITY Posted on Aug 3rd 2026

Amanta Healthcare informs about analyst meet

Amanta Healthcare has informed that an Analyst(s)/ Investors Earnings group Conference Call is scheduled to be held on Thursday, August 6, 2026 at 11:00 AM (IST) to discuss with the investors the financial performance and business updates of the Company for the quarter ended June 30, 2026. Dial in details for the call with registration link is enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
24
2026
EQUITY Posted on Aug 24th 2026

Sanjivani Paranteral informs about scrutinizers report

Further to letter dated 23rd July, 2026, Sanjivani Paranteral has informed that pursuant to Section 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, the members of the Company have duly approved, through remote e-voting facility the special business as specified in the Postal Ballot Notice dated 23rd July, 2026. The details of the voting results in the format prescribed under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Scrutinizer’s Report is enclosed. 
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
24
2026
EQUITY Posted on Aug 24th 2026

Gujarat Kidney and Super Speciality informs about voting results of postal ballot

Gujarat Kidney and Super Speciality has informed that this is with reference to Postal Ballot Notice dated 09.07.2026, seeking approval of shareholders of the Company by way of Postal Ballot (remote e-voting) on the special resolution: Variation in the Objects / terms of utilisation of the Initial Public Offering (‘IPO’) proceeds. The voting on Postal Ballot concluded at 5.00 pm (IST) on Saturday, August 22, 2026 and the Scrutinizer has submitted their report on Postal Ballot (remote e-voting) on the same day. Pursuant to Regulation 44(3) of SEBI (LODR) Regulations 2015, the Company has informed that the resolution has been passed with requisite majority. In this regard, it has attached the voting results of the Postal Ballot in compliance with Regulation 44(3) of SEBI (LODR) Regulations 2015 alongwith the report of Scrutinizer on remote e-voting annexed as Annexure - A. The above information is also available on the company’s website at www.gujaratsuperspecialityhospital.com.

The above information is a part of company’s filings submitted to BSE.  
Read More
Aug
24
2026
EQUITY Posted on Aug 24th 2026

Zenotech Laboratories informs about press release

Zenotech Laboratories has informed that the Company has published newspaper advertisements [All editions of Business Standard (in English) and Hyderabad Edition of Telugu Prabha (in Telugu)] on August 24, 2026 containing information about 37th Annual General Meeting of the Company to be held on Friday, September 25, 2026 at 10:30 am IST through Video Conferencing. Copies of newspaper clippings are enclosed and also available on the website of the Company at www.zenotechlab.com.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Amanta Healthcare Ltd. ?

The current share price of Amanta Healthcare Ltd. is ₹205.17 as of 2026-08-24.

The market capitalisation of Amanta Healthcare Ltd. is ₹758.53 as of 2026-08-21.

The 1-year return of Amanta Healthcare Ltd. is % as of .

The P/E ratio of Amanta Healthcare Ltd. is 0.00 as of 2026-08-24.

The 52-week high and low of Amanta Healthcare Ltd. are ₹195.83 and ₹92.00, respectively, as of 2026-08-24.

The dividend yield of Amanta Healthcare Ltd. is 0.0% as of2026-08-21.

You can buy Amanta Healthcare Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Amanta Healthcare Ltd. is Bhavesh Patel.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore